Clinical and Molecular Hepatology  2017;23(2):123-124

doi:10.3350/cmh.2017.0107

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?.

Do Young KIM 1

Affiliations

+expand

Keywords

Hepatocellular carcinoma; Sorafenib; Hepatic arterial infusion chemotherapy; Metronomic chemotherapy

Country

Republic of Korea

Language

English

Abstract

No abstract available.